(Q48530314)

12 February 2018

title

C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. (English)

1 reference

12 February 2018

0 references

0 references

2

1 reference

12 February 2018

author name string

Frank P Zemlan

1

1 reference

12 February 2018

J Jeffery Mulchahey

3

1 reference

12 February 2018

S Prasad Gabbita

4

1 reference

12 February 2018

William S Rosenberg

5

1 reference

12 February 2018

Samuel G Speciale

6

1 reference

12 February 2018

Mario Zuccarello

7

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

12 February 2018

published in

Brain Research

1 reference

12 February 2018

volume

947

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

131-139

1 reference

12 February 2018

A trial of the effect of nimodipine on outcome after head injury

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Systematic Selection of Prognostic Features in Patients with Severe Head Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Prediction tree for severely head-injured patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Clinical trials in traumatic brain injury. What can we learn from previous studies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. The European Study Group on Nimodipine in Severe Head Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Imaging of closed head injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

The pathology of brain ischaemia and possibilities for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tSAH Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Hypothermia as an adjunctive treatment for severe bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Developmentally regulated expression of specific tau sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Evaluation of designs for clinical trials of neuroprotective agents in head injury. European Brain Injury Consortium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Axonal cytoskeletal responses to nondisruptive axonal injury and the short-term effects of posttraumatic hypothermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: an immunofluorescence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Extracellular and cerebrospinal fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Predicting survival using simple clinical variables: a case study in traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Microtubule-associated protein 2 levels decrease in hippocampus following traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Assessment and prognosis of coma after head injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902920-7

10.1016/S0006-8993(02)02920-7

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

12144861

1 reference

12 February 2018